sumatriptan has been researched along with beta-endorphin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Facchinetti, F; Fioroni, L; Genazzani, AR; Nappi, G; Nappi, RE; Sances, G | 1 |
Gong, M; Guo, L; Ma, L; Qiu, F; Wu, S | 1 |
1 trial(s) available for sumatriptan and beta-endorphin
Article | Year |
---|---|
The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors.
Topics: Adrenocorticotropic Hormone; Adult; beta-Endorphin; Drug Evaluation; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Injections, Subcutaneous; Male; Pituitary-Adrenal System; Prolactin; Receptors, Serotonin; Single-Blind Method; Stimulation, Chemical; Sumatriptan | 1994 |
1 other study(ies) available for sumatriptan and beta-endorphin
Article | Year |
---|---|
Identification and quantification of the quality markers and anti-migraine active components in Chuanxiong Rhizoma and Cyperi Rhizoma herbal pair based on chemometric analysis between chemical constituents and pharmacological effects.
Topics: Animals; beta-Endorphin; Brain Stem; Calcitonin Gene-Related Peptide; Cluster Analysis; Drugs, Chinese Herbal; Male; Neural Networks, Computer; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Rhizome; Serotonin; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Vasoactive Intestinal Peptide | 2020 |